Vaccination News Home Page

http://ije.oupjournals.org/cgi/content/abstract/31/5/968

OUP Int. J. Epidemiol.
 

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Full Text of this Article
Reprint (PDF) Version of this Article
Similar articles found in:
Int. J. Epidemiol. Online
PubMed
PubMed Citation
This Article has been cited by:
other online articles
Search Medline for articles by:
Uzicanin, A. || Strebel, P.
Alert me when:
new articles cite this article
 
Download to Citation Manager

International Journal of Epidemiology 2002;31:968-976
© International Epidemiological Association 2002

 


Special Theme: Infectious Diseases

Impact of the 1996–1997 supplementary measles vaccination campaigns in South Africa

Amra Uzicanina,b, Rudi Eggersc,d, Elize Webbc, Bernice Harrise, Dave Durrheime, Gboyega Ogunbanjoe,f, Veronica Isaacsg, Anthony Hawkridgeg, Robin Biellikh and Peter Strebelb

a Epidemic Intelligence Service, Epidemiology Program Office,
b National Immunization Program, Centers for Disease Control and Prevention, Atlanta, USA.
c Formerly, Expanded Programme on Immunisation, Department of Health, Pretoria, South Africa.
d Current affiliation: World Health Organization Office for East Africa, Nairobi, Kenya.
e Communicable Disease Control, Mpumalanga Department of Health, Nelspruit, South Africa.
f Department of Family Medicine and Primary Health Care, Pretoria, South Africa.
g Communicable Disease Control, Western Cape Department of Health, Cape Town, South Africa.
h World Health Organization Regional Office for Africa, Harare, Zimbabwe.

Dr Amra Uzicanin, National Immunization Program, Mailstop E-05, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA. E-mail: auzicanin@cdc.gov

Abstract

Background In South Africa, as part of an effort to eliminate indigenous measles by 2002, vaccination campaigns were conducted in 1996–1997 targeting all children aged 9 months to 14 years; coverage was estimated at 85%. The impact of the campaigns on measles disease burden was evaluated in 1999.

Methods We analysed routine measles surveillance data and undertook a retrospective review of hospital registers in two of South Africa’s nine provinces.

Results In Mpumalanga in the pre-campaign years (1992–1996), 4498 measles cases and 6 deaths were reported; 182 cases and no deaths were reported in 1997–1998. Hospital registers showed 1647 measles hospitalizations and 11 deaths in the pre-campaign period, and 60 hospitalizations and no deaths after the campaign (1997–April 1999). In Western Cape in pre-campaign years (1992–1997), 5164 measles cases and 19 deaths were reported; 132 cases and no deaths were reported in 1998. Hospital registers showed 736 measles hospitalizations and 23 deaths in the pre-campaign period, and 29 measles hospitalizations and no deaths post-campaign (1998–July 1999).

Conclusions Study findings indicate that reported measles cases, measles-related hospitalizations and deaths were considerably reduced in both provinces after the campaign compared with the pre-campaign period. Longer observation is needed to evaluate the long-term impact of the campaigns.

Keywords Measles, vaccination, South Africa

Accepted 13 June 2002


This article has been cited by other articles:

 


 
Home page
 
Int. J. Epidemiol.Home page
A. R Hinman
Commentary: Accelerated measles control/measles elimination in southern Africa
Int. J. Epidemiol., October 1, 2002; 31(5): 976 - 977.
[Full Text] [PDF]




 

 


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Copyright © 2002 International Epidemiological Association.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.